Prasad S. Adusumilli, MD, FACS

Articles by Prasad S. Adusumilli, MD, FACS

Dr. Adusumilli on the Development of CAR T Cells in Solid Tumors

February 28th 2020

Prasad S. Adusumilli, MD, FACS, discusses the current role of chimeric antigen receptor T-cell therapy as treatment of patients with solid tumors and how this is evolving compared to CAR T cells in hematologic malignancies.

Latest Updated Articles

Dr. Adusumilli on the Development of CAR T Cells in Solid Tumors
Published: February 28th 2020 | Updated:

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD

Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant

Dr Neff on the Accuracy and Feasibility of Self-Collected HPV Testing in Cervical Cancer

Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP